Medical specialists from Canada tagged as investigators in clinical trials studying Urinary Bladder, Overactive

Total 7 results

Erin Kelly, MD FRCSC
Seen in:
- Alberta, Edmonton, Urogynecology Clinic - Royal Alexandra Hospital
Trials:
- NCT04444440 (Principal Investigator)
Conditions:
- Postoperative Urinary Tract Infection;
- Idiopathic Overactive Bladder
Gary Gray, MD
Seen in:
- Alberta, Edmonton, Northern Alberta Urology Center
Trials:
- NCT02873312 (Principal Investigator)
Conditions:
- Overactive Bladder
Jane Schulz, MD FRCSC
Seen in:
- Alberta, Edmonton, Urogynecology Clinic - Royal Alexandra Hospital
Trials:
- NCT04444440 (Sub-Investigator)
Conditions:
- Postoperative Urinary Tract Infection;
- Idiopathic Overactive Bladder
Le Mai Tu, MD
Seen in:
- Quebec, Sherbrooke, University of Sherbrooke
Trials:
- NCT02873312 (Principal Investigator)
Conditions:
- Overactive Bladder
Magdy Hassouna, MD
Seen in:
- Ontario, Toronto, Toronto Western Hospital
Trials:
- NCT02873312 (Principal Investigator)
Conditions:
- Overactive Bladder
Nathan Hoag, MD
Seen in:
- British Columbia, Victoria, Silverado Research, Inc
Trials:
- NCT02873312 (Principal Investigator)
Conditions:
- Overactive Bladder
Paul Groves, MD FRCSC
Seen in:
- Alberta, Edmonton, Urogynecology Clinic - Royal Alexandra Hospital
Trials:
- NCT04444440 (Sub-Investigator)
Conditions:
- Postoperative Urinary Tract Infection;
- Idiopathic Overactive Bladder

Clinical Trials on Urinary Bladder, Overactive

Merck Sharp & Dohme LLC

Terminated

A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004)

Overactive Bladder | Overactive Urinary Bladder
Ankara Yildirim Beyazıt University

Completed

Comparison of Different Treatments for Overactive Bladder Syndrome

Overactive Bladder | Overactive Detrusor | Overactive Bladder Syndrome

Turkey
Pfizer

Completed

Drug Use Investigation for Toviaz

Overactive Bladder (OAB)
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Detrol LA In Men With Overactive Bladder.

Overactive Bladder (OAB)

United States, Canada, Germany, Korea, Republic of, Spain, Turkey, Taiwan, Italy, Slovakia, Denmark, South Africa, United Kingdom, Mexico, Sweden, Norway
Medstar Health Research Institute
Columbia University; University of Michigan; University of New Mexico; Methodist...

Terminated

PTNS vs Botox of Refractory OAB (TROOP)

Overactive Bladder (OAB)

United States
Astellas Pharma Global Development, Inc.

Completed

A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB) (PREFER)

Overactive Bladder (OAB)

United States, Canada
Loyola University
Astellas Pharma Inc

Completed

Validation of a Real-time Urodynamic Measure of Urinary Urgency

Overactive Bladder Syndrome

United States
Beijing Pins Medical Co., Ltd

Unknown

A Study to Compare the Efficacy and Safety of Ultrasound Guided Lead Implantation for Sacral Neuromodulation (SNM) in Subjects With Overactive Bladder (OAB) With X-Ray Guided Technique

Refractory Overactive Bladder
Maastricht University Medical Center

Unknown

Non-Micturation Bladder Activity in Relation to Self-Consciousness During Filling Phase and Sensation Measurement During the Filling Phase

Lower Urinary Tract Symptoms | Overactive Bladder Syndrome

Netherlands
Pamukkale University

Completed

Intravaginal Electrical Stimulation in Idiopathic Overactive Bladder

Electrical Stimulation | Idiopathic Overactive Bladder | Bladder Training

Turkey

Medical specialists from Canada tagged as investigators in clinical trials studying Urinary Bladder, Overactive

Clinical Trials on Urinary Bladder, Overactive

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations